Hematopoiesis-restricted minor histocompatibility antigens HA-1- or HA-2-specific T cells can induce complete remissions of relapsed leukemia (Q34808353)

From Wikidata

Jump to navigation Jump to search

scholarly article

Language	Label	Description	Also known as
English	Hematopoiesis-restricted minor histocompatibility antigens HA-1- or HA-2-specific T cells can induce complete remissions of relapsed leukemia	scholarly article

Statements

scholarly article

1 reference

Europe PubMed Central

4 August 2017

Hematopoiesis-restricted minor histocompatibility antigens HA-1- or HA-2-specific T cells can induce complete remissions of relapsed leukemia (English)

1 reference

Europe PubMed Central

4 August 2017

0 references

1 reference

based on heuristic

inferred from title

4

object named as

Els Goulmy

1 reference

Europe PubMed Central

4 August 2017

9

object named as

Tuna Mutis

1 reference

Europe PubMed Central

4 August 2017

Mirjam H.M. Heemskerk

2

object named as

Mirjam H M Heemskerk

1 reference

Europe PubMed Central

4 August 2017

author name string

W A Erik Marijt

1

1 reference

Europe PubMed Central

4 August 2017

Freke M Kloosterboer

3

1 reference

Europe PubMed Central

4 August 2017

Michel G D Kester

5

1 reference

Europe PubMed Central

4 August 2017

Menno A W G van der Hoorn

6

1 reference

Europe PubMed Central

4 August 2017

Simone A P van Luxemburg-Heys

7

1 reference

Europe PubMed Central

4 August 2017

Manja Hoogeboom

8

1 reference

Europe PubMed Central

4 August 2017

Jan Wouter Drijfhout

10

1 reference

Europe PubMed Central

4 August 2017

Jon J van Rood

11

1 reference

Europe PubMed Central

4 August 2017

Roel Willemze

12

1 reference

Europe PubMed Central

4 August 2017

J H Frederik Falkenburg

13

1 reference

Europe PubMed Central

4 August 2017

language of work or name

0 references

publication date

24 February 2003

1 reference

Europe PubMed Central

4 August 2017

Proceedings of the National Academy of Sciences of the United States of America

1 reference

Europe PubMed Central

4 August 2017

100

1 reference

Europe PubMed Central

4 August 2017

2742-2747

1 reference

Europe PubMed Central

4 August 2017

5

1 reference

Europe PubMed Central

4 August 2017

Direct evidence that leukemic cells present HLA-associated immunogenic peptides derived from the BCR-ABL b3a2 fusion protein

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=151411

8 July 2018

High frequency of cytolytic T lymphocytes directed against a tumor-specific mutated antigen detectable with HLA tetramers in the blood of a lung carcinoma patient with long survival

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=151411

8 July 2018

Analysis of a natural immune response against tumor antigens in a melanoma survivor: lessons applicable to clinical trial evaluations.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=151411

8 July 2018

The immunogenicity of a new human minor histocompatibility antigen results from differential antigen processing

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=151411

8 July 2018

Peptide-MHC class I tetrameric complexes display exquisite ligand specificity.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=151411

8 July 2018

UTY gene codes for an HLA-B60-restricted human male-specific minor histocompatibility antigen involved in stem cell graft rejection: characterization of the critical polymorphic amino acid residues for T-cell recognition.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=151411

8 July 2018

Donor lymphocyte infusions for relapsed multiple myeloma after allogeneic stem-cell transplantation: predictive factors for response and long-term outcome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=151411

8 July 2018

The human UTY gene encodes a novel HLA-B8-restricted H-Y antigen.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=151411

8 July 2018

A human minor histocompatibility antigen specific for B cell acute lymphoblastic leukemia.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=151411

8 July 2018

Quantitation of minimal residual disease in Philadelphia chromosome positive chronic myeloid leukaemia patients using real-time quantitative RT-PCR.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=151411

8 July 2018

T cells recognizing leukemic CD34(+) progenitor cells mediate the antileukemic effect of donor lymphocyte infusions for relapsed chronic myeloid leukemia after allogeneic stem cell transplantation.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=151411

8 July 2018

Direct visualization of antigen-specific CD8+ T cells during the primary immune response to Epstein-Barr virus In vivo

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=151411

8 July 2018

The HLA-A*0201-restricted H-Y antigen contains a posttranslationally modified cysteine that significantly affects T cell recognition

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=151411

8 July 2018

Phenotypic analysis of antigen-specific T lymphocytes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=151411

8 July 2018

Human minor histocompatibility antigens

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=151411

8 July 2018

Human H-Y: a male-specific histocompatibility antigen derived from the SMCY protein

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=151411

8 July 2018

Isolation and characterization of a major tandem repeat family from the human X chromosome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=151411

8 July 2018

Rejection of bone-marrow graft by recipient-derived cytotoxic T lymphocytes against minor histocompatibility antigens

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=151411

8 July 2018

Y-antigen killing by T cells of women is restricted by HLA

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=151411

8 July 2018

HLA Restriction of non-HLA-A, -B, -C and -D Cell Mediated Lympholysis (CML)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=151411

8 July 2018

Long-term follow-up of patients who achieved complete remission after donor leukocyte infusions.

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.0530192100

21 January 2018

Tetramer-based quantification of cytomegalovirus (CMV)-specific CD8+ T lymphocytes in T-cell-depleted stem cell grafts and after transplantation may identify patients at risk for progressive CMV infection

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.0530192100

21 January 2018

Adoptive tumor therapy with T lymphocytes enriched through an IFN-gamma capture assay.

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.0530192100

21 January 2018

High Frequency of Cytomegalovirus‐Specific Cytotoxic T‐Effector Cells in HLA‐A*0201–Positive Subjects during Multiple Viral Coinfections

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.0530192100

21 January 2018

Quantitation of HIV-1-Specific Cytotoxic T Lymphocytes and Plasma Load of Viral RNA

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.0530192100

21 January 2018

Donor leukocyte infusions for multiple myeloma

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.0530192100

21 January 2018

Donor lymphocyte infusion enhances remission status in patients with persistent disease after allografting for multiple myeloma

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.0530192100

21 January 2018

Evidence that specific T lymphocytes may participate in the elimination of chronic myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.0530192100

21 January 2018

Tetrameric HLA class I-minor histocompatibility antigen peptide complexes demonstrate minor histocompatibility antigen-specific cytotoxic T lymphocytes in patients with graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.0530192100

21 January 2018

A case of isodicentric 7p as sole abnormality in a patient with acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.0530192100

21 January 2018

Characterisation of a human Y chromosome repeated sequence and related sequences in higher primates

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.0530192100

21 January 2018

Mismatches of minor histocompatibility antigens between HLA-identical donors and recipients and the development of graft-versus-host disease after bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.0530192100

21 January 2018

In situ dissection of the graft-versus-host activities of cytotoxic T cells specific for minor histocompatibility antigens

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.0530192100

21 January 2018

Prospective trial of chemotherapy and donor leukocyte infusions for relapse of advanced myeloid malignancies after allogeneic stem-cell transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/12601144

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/12601144

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tissue distribution of human minor histocompatibility antigens. Ubiquitous versus restricted tissue distribution indicates heterogeneity among human cytotoxic T lymphocyte-defined non-MHC antigens

1 reference

https://pubmed.ncbi.nlm.nih.gov/12601144

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Donor leukocyte infusions for chronic myeloid leukemia relapsed after allogeneic bone marrow transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/12601144

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adoptive immunotherapy evaluating escalating doses of donor leukocytes for relapse of chronic myeloid leukemia after bone marrow transplantation: separation of graft-versus-leukemia responses from graft-versus-host disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/12601144

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/12601144

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Multiple minor histocompatibility antigen-specific cytotoxic T lymphocyte clones can be generated during graft rejection after HLA-identical bone marrow transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/12601144

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/12601144

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Feasibility of immunotherapy of relapsed leukemia with ex vivo-generated cytotoxic T lymphocytes specific for hematopoietic system-restricted minor histocompatibility antigens

1 reference

https://pubmed.ncbi.nlm.nih.gov/12601144

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of single-dose and escalating-dose regimens of donor lymphocyte infusion for relapse after allografting for chronic myeloid leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/12601144

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

DFFRY codes for a new human male-specific minor transplantation antigen involved in bone marrow graft rejection

1 reference

https://pubmed.ncbi.nlm.nih.gov/12601144

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of relapsed leukemia after unrelated donor marrow transplantation with unrelated donor leukocyte infusions

1 reference

https://pubmed.ncbi.nlm.nih.gov/12601144

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1073/PNAS.0530192100

1 reference

Europe PubMed Central

4 August 2017

2003PNAS..100.2742M

0 references

1 reference

Europe PubMed Central

4 August 2017

1 reference

Europe PubMed Central

4 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34808353&oldid=2142038869"